Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C

Direct-acting antivirals (DAA) are highly effective for the treatment of hepatitis C (HCV), although there are limited data on the safety and efficacy of DAA therapy in hepatitis C-positive individuals awaiting liver transplantation for hepatocellular carcinoma (HCC). METHODS: We conducted a retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Chung Sang, Yang, Ju Dong, Mousa, Omar Y., Nelson, Kevin M., Pungpapong, Surakit, Keaveny, Andrew, Aqel, Bashar A., Vargas, Hugo, Dickson, Rolland C., Watt, Kymberly, Gores, Gregory J., Roberts, Lewis R., Leise, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725260/
https://www.ncbi.nlm.nih.gov/pubmed/33324740
http://dx.doi.org/10.1097/TXD.0000000000001049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725260/
https://www.ncbi.nlm.nih.gov/pubmed/33324740
http://dx.doi.org/10.1097/TXD.0000000000001049

Ejemplares similares